{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:20:26Z","timestamp":1778858426977,"version":"3.51.4"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.pnpbp.2006.06.021","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T21:44:58Z","timestamp":1154555098000},"page":"308-310","source":"Crossref","is-referenced-by-count":6,"title":["Perospirone in treatment of Huntington's disease: A first case report"],"prefix":"10.1016","volume":"31","author":[{"given":"Tomohide","family":"Roppongi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Togo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Asami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Shiozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Kawanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Hirayasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2006.06.021_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/1353-8020(95)00011-T","article-title":"The pathophysiology of chorea\/ballism and Parkinsonism","volume":"1","author":"Albin","year":"1995","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.pnpbp.2006.06.021_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT1A agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.06.021_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s00415-002-0741-1","article-title":"Quetiapine in Huntington's disease: a first case report","volume":"249","author":"Bonelli","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.pnpbp.2006.06.021_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00004850-200403000-00001","article-title":"Huntington's disease: present treatments and future therapeutic modalities","volume":"19","author":"Bonelli","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.06.021_bib5","first-page":"121","article-title":"Perospirone (Sumitomo Pharmaceuticals)","volume":"3","author":"de Paulis","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pnpbp.2006.06.021_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group","volume":"11","year":"1996","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2006.06.021_bib7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep"},{"key":"10.1016\/j.pnpbp.2006.06.021_bib8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1034\/j.1600-0404.2002.01197.x","article-title":"Olanzapine in Huntington's disease","volume":"105","author":"Paleacu","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.pnpbp.2006.06.021_bib9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00004714-199704000-00023","article-title":"Risperidone in treatment of choreoathetosis of Huntington's disease","volume":"17","author":"Parsa","year":"1997","journal-title":"J Clin Psychopharmacol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606002843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606002843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T16:20:53Z","timestamp":1547482853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584606002843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0278584606002843"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2006.06.021","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}